Hee-Je Kim, MD, PhD - The Catholic University of Korea - Professor

Hee-Je Kim

MD, PhD

The Catholic University of Korea

Professor

Seoul | Korea, Republic of

Main Specialties: Allergy & Immunology, Hematology, Hematology & Oncology, Internal Medicine, Medical Genetics

Additional Specialties: AML

ORCID logohttps://orcid.org/0000-0003-4098-3366

Hee-Je Kim, MD, PhD - The Catholic University of Korea - Professor

Hee-Je Kim

MD, PhD

Introduction

Primary Affiliation: The Catholic University of Korea - Seoul , Korea, Republic of

Specialties:

Additional Specialties:

Research Interests:

Publications

173Publications

4147Reads

70Profile Views

406PubMed Central Citations

Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B.

Dig Dis Sci 2019 Oct 13;64(10):2992-3000. Epub 2019 Apr 13.

Division of Hematology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10620-019-05614-6
Publisher Site
http://dx.doi.org/10.1007/s10620-019-05614-6DOI Listing
October 2019
25 Reads
2.550 Impact Factor

Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2019 Oct 10;25(10):1933-1943. Epub 2019 Jun 10.

Department of Hematology, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.06.001DOI Listing
October 2019
15 Reads
3.404 Impact Factor

Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemia.

Eur J Haematol 2019 Oct 21;103(4):433-441. Epub 2019 Aug 21.

Division of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13308DOI Listing
October 2019
4 Reads
2.066 Impact Factor

WT1 Measurable Residual Disease Assay in Patients With Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation: Optimal Time Points, Thresholds, and Candidates.

Biol Blood Marrow Transplant 2019 Oct 4;25(10):1925-1932. Epub 2019 Jun 4.

Department of Hematology, Division of acute leukemia, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.05.033DOI Listing
October 2019
15 Reads
3.404 Impact Factor

Progressive hyperleukocytosis is a relevant predictive marker for differentiation syndrome, early death, and subsequent relapse in acute promyelocytic leukemia.

Sci Rep 2019 Aug 15;9(1):11935. Epub 2019 Aug 15.

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-47937-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695497PMC
August 2019
3 Reads
5.078 Impact Factor

Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma.

Ann Hematol 2019 Jul 14;98(7):1743-1753. Epub 2019 May 14.

Division of Lymphoma-Myeloma, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, #505, Banpo-Dong, Seocho-Ku, Seoul, 06591, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03714-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591200PMC
July 2019
3 Reads
2.634 Impact Factor

A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation.

Int J Hematol 2019 Jul 15. Epub 2019 Jul 15.

Department of Internal Medicine, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Banpo-daero 222, Seocho-Gu, Seoul, 06591, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02702-1DOI Listing
July 2019
4 Reads
1.679 Impact Factor

Changes in trabecular bone score and bone mineral density following allogeneic hematopoietic stem cell transplantation.

Bone 2019 Jul 6;124:40-46. Epub 2019 Apr 6.

Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2019.04.004DOI Listing
July 2019
19 Reads

Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial.

Bone Marrow Transplant 2019 Jun 8;54(6):903-906. Epub 2018 Nov 8.

Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0383-2
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0383-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760543PMC
June 2019
22 Reads
3.570 Impact Factor

Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Clin Lymphoma Myeloma Leuk 2019 Jun 30;19(6):345-355.e7. Epub 2019 Mar 30.

Division of Lymphoma-Myeloma, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Institute for Translational Research and Molecular Imaging, Catholic Institutes of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Laboratory of Immune Regulation, Convergent Research Consortium for Immunologic Disease, Seoul St. Mary's Hospital, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.03.023DOI Listing
June 2019
4 Reads

Different prognostic effects of core-binding factor positive AML with Korean AML registry data.

Ann Hematol 2019 May 13;98(5):1135-1147. Epub 2019 Feb 13.

Division of Hematology, Department of Internal Medicine, Catholic Hematology Hospital, Seoul St. Mary's Hospital, Leukemia Research Institute, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03624-yDOI Listing
May 2019
3 Reads
2.634 Impact Factor

Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy.

Int J Mol Sci 2019 May 30;20(11). Epub 2019 May 30.

Catholic Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20112666DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600658PMC
May 2019
1 Read
2.862 Impact Factor

Reclassification of Acute Myeloid Leukemia According to the 2016 WHO Classification.

Ann Lab Med 2019 May;39(3):311-316

Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3343/alm.2019.39.3.311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340847PMC
May 2019
10 Reads
1.481 Impact Factor

Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia.

Cancer 2019 Mar 6;125(6):873-883. Epub 2018 Dec 6.

Department of Hematology, Catholic Hematology Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31874
Publisher Site
http://dx.doi.org/10.1002/cncr.31874DOI Listing
March 2019
53 Reads
4.889 Impact Factor

Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation.

J Immunother Cancer 2019 Feb 7;7(1):35. Epub 2019 Feb 7.

Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpodae-ro, Seocho-gu, Seoul, 06591, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-018-0491-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367772PMC
February 2019
5 Reads

Autologous hematopoietic cell transplantation using dose-reduced intravenous busulfan, melphalan, and thiotepa for high-risk or relapsed lymphomas.

Bone Marrow Transplant 2019 02 6;54(2):330-333. Epub 2018 Aug 6.

Department of Hematology, Leukemia Research Institute, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0289-zDOI Listing
February 2019
7 Reads
3.570 Impact Factor

Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy.

Haematologica 2019 Feb 13;104(2):269-276. Epub 2018 Sep 13.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.198655DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355492PMC
February 2019
40 Reads
5.870 Impact Factor

Germline CEBPA mutations in Korean patients with acute myeloid leukemia.

Leuk Res 2019 01 11;76:84-86. Epub 2018 Dec 11.

Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.12.003DOI Listing
January 2019
7 Reads
2.351 Impact Factor

Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome.

Biol Blood Marrow Transplant 2019 01 10;25(1):63-72. Epub 2018 Aug 10.

Division of Hematology, Department of Internal Medicine, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea; Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183045
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.08.004DOI Listing
January 2019
41 Reads
3.404 Impact Factor

Enhanced Anti-Leukemic Effects through Induction of Immunomodulating Microenvironment by Blocking CXCR4 and PD-L1 in an AML Mouse Model.

Immunol Invest 2019 Jan 11;48(1):96-105. Epub 2018 Sep 11.

a Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine , The Catholic University of Korea , Seoul , Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08820139.2018.1497057DOI Listing
January 2019
17 Reads
1.903 Impact Factor

Low frequency of CD3CD4CD161 T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment.

Ann Hematol 2018 Nov 25;97(11):2163-2171. Epub 2018 Jun 25.

Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-Gu, Seoul, 06591, South Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-018-3401-y
Publisher Site
http://dx.doi.org/10.1007/s00277-018-3401-yDOI Listing
November 2018
14 Reads
2.634 Impact Factor

Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose.

Am J Hematol 2018 11 30;93(11):1368-1375. Epub 2018 Sep 30.

Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25257
Publisher Site
http://dx.doi.org/10.1002/ajh.25257DOI Listing
November 2018
14 Reads
3.800 Impact Factor

Successful outcomes of second hematopoietic stem cell transplantation with total nodal irradiation and ATG conditioning for graft failure in adult patients with severe aplastic anemia.

Bone Marrow Transplant 2018 10 21;53(10):1270-1277. Epub 2018 Mar 21.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul. St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0154-0DOI Listing
October 2018
60 Reads
3.570 Impact Factor

PCM1-JAK2 Fusion in a Patient With Acute Myeloid Leukemia.

Ann Lab Med 2018 09;38(5):492-494

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, Leukemia Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3343/alm.2018.38.5.492DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973928PMC
September 2018
7 Reads
1.481 Impact Factor

Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults.

Biol Blood Marrow Transplant 2018 08 23;24(8):1621-1628. Epub 2018 Apr 23.

Department of Hematology, Leukemia Research Institute, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.04.020DOI Listing
August 2018
39 Reads
3.404 Impact Factor

Association of MICA and MICB polymorphisms with the susceptibility of leukemia in Korean patients.

Blood Cancer J 2018 06 12;8(6):58. Epub 2018 Jun 12.

Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0092-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997647PMC
June 2018
7 Reads
2.884 Impact Factor

Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients.

Ann Hematol 2018 Jun 2;97(6):955-965. Epub 2018 Mar 2.

Department of Hematology/Oncology, Ewha Womans University College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3260-6DOI Listing
June 2018
42 Reads
2.634 Impact Factor

Effect of High VEGF-C mRNA Expression on Achievement of Complete Remission in Adult Acute Myeloid Leukemia.

Transl Oncol 2018 Jun 12;11(3):567-574. Epub 2018 Mar 12.

Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea; Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2018.02.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854918PMC
June 2018
9 Reads

Comparison of transplant-specific prognostic scoring systems in haploidentical transplantation for myelodysplastic syndrome.

Eur J Haematol 2018 May 14. Epub 2018 May 14.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13095DOI Listing
May 2018
19 Reads
2.070 Impact Factor

Prognostic Prediction Model for Second Allogeneic Stem-Cell Transplantation in Patients With Relapsed Acute Myeloid Leukemia: Single-Center Report.

Clin Lymphoma Myeloma Leuk 2018 04 17;18(4):e167-e182. Epub 2018 Feb 17.

Catholic Blood and Marrow Transplantation Center, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.02.009DOI Listing
April 2018
57 Reads

Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.

Hematol Oncol 2017 Mar 18;35(1):17-24. Epub 2015 Mar 18.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2201DOI Listing
March 2017
41 Reads
3.084 Impact Factor

Clinical significance of pre-transplant circulating CD3 CD4 CD161 cell frequency on the occurrence of neutropenic infections after allogeneic stem cell transplantation.

Transpl Infect Dis 2017 Feb 10;19(1). Epub 2017 Jan 10.

Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tid.12643DOI Listing
February 2017
59 Reads
2 Citations

Characteristics and Survival Outcome Analysis of Extramedullary Involvement in Adult Patients With t(8;21) Acute Myeloid Leukemia.

Clin Lymphoma Myeloma Leuk 2017 01 17;17(1):38-45.e2. Epub 2016 Sep 17.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Leukemia Research Institute, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.09.001DOI Listing
January 2017
50 Reads

Budding Yeast Cells in Peripheral Blood Smear: Clue to Candidemia.

Infect Chemother 2016 Dec;48(4):342-343

The Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3947/ic.2016.48.4.342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204016PMC
December 2016
6 Reads

Clinical manifestations of autoimmune disease-related non-Hodgkin lymphoma: a Korean single-center, retrospective clinical study.

Korean J Intern Med 2016 Sep 7;31(5):944-52. Epub 2016 Jul 7.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2015.097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016281PMC
September 2016
30 Reads

Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide study.

Ann Hematol 2016 Aug 26;95(8):1223-32. Epub 2016 May 26.

Department of Laboratory Medicine, School of Medicine, Kyung Hee University, 23, Kyungheedae-ro, Dongdaemun-gu, Seoul, 130-872, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2691-1DOI Listing
August 2016
82 Reads
2 Citations
2.634 Impact Factor

Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma.

Cancer Immunol Immunother 2016 08 24;65(8):983-94. Epub 2016 Jun 24.

Department of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, #222 Banpodaero, Seocho-Gu, Seoul, 06591, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-016-1861-2DOI Listing
August 2016
80 Reads
1 Citation
3.941 Impact Factor

Risk factors and outcomes of hepatitis B virus reactivation in hepatitis B surface antigen negative patients with hematological malignancies.

Hepatol Res 2016 Jun 5;46(7):657-68. Epub 2015 Nov 5.

Division of Hepatology, Department of Internal Medicine, Seoul St Mary's Hospital, College of Medicine, The Catholic University of South Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.12603DOI Listing
June 2016
19 Reads
3 Citations
2.220 Impact Factor

Co-culture with podoplanin+ cells protects leukemic blast cells with leukemia-associated antigens in the tumor microenvironment.

Mol Med Rep 2016 May 18;13(5):3849-57. Epub 2016 Mar 18.

Leukemia Research Institute, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 137‑701, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mmr.2016.5009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838120PMC
May 2016
22 Reads
1.484 Impact Factor

Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Respir Res 2016 05 26;17(1):63. Epub 2016 May 26.

Division of Hematology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://respiratory-research.biomedcentral.com/articles/10.11
Publisher Site
http://dx.doi.org/10.1186/s12931-016-0380-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882858PMC
May 2016
36 Reads
2 Citations

Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission.

Oncotarget 2016 Mar;7(13):17230-41

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.7347DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941383PMC
March 2016
28 Reads
3 Citations
6.360 Impact Factor

Negative Impact of Unidirectional Host-versus-Graft Killer Cell Immunoglobulin-like Receptor Ligand Mismatch on Transplantation Outcomes after Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2016 Feb 28;22(2):316-323. Epub 2015 Sep 28.

Catholic Blood and Marrow Transplantation Center, Department of Hematology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Cancer Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.09.018DOI Listing
February 2016
34 Reads
2 Citations
3.404 Impact Factor

Pseudozyma aphidis fungaemia with invasive fungal pneumonia in a patient with acute myeloid leukaemia: case report and literature review.

Mycoses 2016 Jan 26;59(1):56-61. Epub 2015 Nov 26.

Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/myc.12435DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738435PMC
January 2016
13 Reads
1 Citation
1.805 Impact Factor

A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.

Oncol Rep 2015 Dec 21;34(6):2880-8. Epub 2015 Sep 21.

Cancer Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2015.4297DOI Listing
December 2015
30 Reads
2 Citations
2.191 Impact Factor

Clinical outcomes of venous thromboembolism with dalteparin therapy in multiple myeloma patients.

Thromb Res 2015 Nov 26;136(5):974-9. Epub 2015 Sep 26.

Hematology, Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2015.09.021DOI Listing
November 2015
41 Reads
2.450 Impact Factor

Bone marrow plasma cell assessment before peripheral blood stem cell mobilization in patients with multiple myeloma undergoing autologous stem cell transplantation.

Biomed Res Int 2014 6;2014:982504. Epub 2014 May 6.

Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, #222 Banpo-daero, Seocho-Gu, Seoul 137-701, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/982504DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033341PMC
November 2015
22 Reads
1 Citation

Determination of posaconazole concentration with LC-MS/MS in adult patients with hematologic malignancy.

Clin Chim Acta 2015 Oct 28;450:220-6. Epub 2015 Aug 28.

Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Vaccine Bio Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2015.08.023DOI Listing
October 2015
34 Reads
4 Citations
2.824 Impact Factor

Model-based adaptive phase I trial design of post-transplant decitabine maintenance in myelodysplastic syndrome.

J Hematol Oncol 2015 Oct 23;8:118. Epub 2015 Oct 23.

Department of Pharmacology, College of Medicine, The Catholic University of Korea, 222 Banpo-Daero, Seochogu, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
https://pdfs.semanticscholar.org/3ecf/84b0c0eee13237326ee87b
Web Search
http://www.jhoonline.org/content/8/1/118
Publisher Site
http://dx.doi.org/10.1186/s13045-015-0208-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619308PMC
October 2015
54 Reads
4 Citations
4.812 Impact Factor

Bone marrow-derived progenitor cells in de novo liver regeneration in liver transplant.

Liver Transpl 2015 Sep 23;21(9):1186-94. Epub 2015 Apr 23.

Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/lt.24099DOI Listing
September 2015
40 Reads
4.241 Impact Factor

Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.

Clin Ther 2015 Sep 15;37(9):2019-27. Epub 2015 Jul 15.

Pharmaceutical Policy & Outcomes Research, School of Pharmacy, Sungkyunkwan University, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2015.06.014DOI Listing
September 2015
49 Reads
2 Citations
2.731 Impact Factor

Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations.

Mycoses 2015 Sep 27;58(9):565-71. Epub 2015 Jul 27.

The Catholic Blood and Marrow Transplantation Centre, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/myc.12357DOI Listing
September 2015
33 Reads
2 Citations
1.805 Impact Factor

Outcome of allogeneic hematopoietic stem cell transplantation for cytogenetically normal AML and identification of high-risk subgroup using WT1 expression in association with NPM1 and FLT3-ITD mutations.

Genes Chromosomes Cancer 2015 Aug 6;54(8):489-499. Epub 2015 Jun 6.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, Seoul St. Mary's Hospital, the Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22260DOI Listing
August 2015
44 Reads
3 Citations
4.041 Impact Factor

Concentrative nucleoside transporter 3 as a prognostic indicator for favorable outcome of t(8;21)-positive acute myeloid leukemia patients after cytarabine-based chemotherapy.

Oncol Rep 2015 Jul 7;34(1):488-94. Epub 2015 May 7.

Division of Life Sciences, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2015.3959DOI Listing
July 2015
32 Reads
1 Citation
2.191 Impact Factor

Equivalent outcome of autologous stem cell transplantation and reduced intensity conditioning stem cell transplantation in acute myeloid leukemia patients with t(8;21).

Acta Haematol 2015 20;133(3):266-76. Epub 2014 Nov 20.

Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000366261DOI Listing
June 2015
51 Reads
1 Citation
0.994 Impact Factor

Clinical significance of nontuberculous mycobacteria from respiratory specimens in stem cell transplantation recipients.

Int J Hematol 2015 May 8;101(5):505-13. Epub 2015 Feb 8.

Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222, Banpo-Daero, Seocho-Gu, Seoul, 137-701, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-015-1745-9DOI Listing
May 2015
15 Reads
1.680 Impact Factor

Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.

Korean J Intern Med 2015 May 29;30(3):362-71. Epub 2015 Apr 29.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2015.30.3.362DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438291PMC
May 2015
66 Reads
3 Citations

Circulating Levels of Adipokines Predict the Occurrence of Acute Graft-versus-host Disease.

Immune Netw 2015 Apr 23;15(2):66-72. Epub 2015 Apr 23.

Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4110/in.2015.15.2.66DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411511PMC
April 2015
24 Reads

Wilms tumor gene 1 expression as a predictive marker for relapse and survival after hematopoietic stem cell transplantation for myelodysplastic syndromes.

Biol Blood Marrow Transplant 2015 Mar 20;21(3):460-7. Epub 2014 Nov 20.

Catholic Blood and Marrow Transplantation Center, The Catholic University of Korea, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.11.008DOI Listing
March 2015
38 Reads
1 Citation
3.404 Impact Factor

Genetic and epigenetic alterations of bone marrow stromal cells in myelodysplastic syndrome and acute myeloid leukemia patients.

Stem Cell Res 2015 Mar 24;14(2):177-84. Epub 2015 Jan 24.

Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Catholic Genetic Laboratory Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2015.01.004DOI Listing
March 2015
19 Reads
6 Citations
3.693 Impact Factor

SOCS1 and SOCS3 are expressed in mononuclear cells in human cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation.

Blood Res 2015 Mar 24;50(1):40-5. Epub 2015 Mar 24.

Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. ; Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2015.50.1.40DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377337PMC
March 2015
44 Reads
1 Citation

Fatal Breakthrough Mucormycosis in an Acute Myelogenous Leukemia Patient while on Posaconazole Prophylaxis.

Infect Chemother 2015 Mar 30;47(1):49-54. Epub 2015 Mar 30.

Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. ; Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3947/ic.2015.47.1.49DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384455PMC
March 2015
22 Reads
5 Citations

Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma.

Ann Hematol 2015 Mar 26;94(3):445-52. Epub 2014 Sep 26.

Hematology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00277-014-2216
Web Search
http://link.springer.com/10.1007/s00277-014-2216-8
Publisher Site
http://dx.doi.org/10.1007/s00277-014-2216-8DOI Listing
March 2015
27 Reads
4 Citations
2.634 Impact Factor

CD161(+) T cells as predictive markers for acute graft-versus-host disease.

Biol Blood Marrow Transplant 2015 Mar 24;21(3):421-8. Epub 2014 Dec 24.

Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, College of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.12.021DOI Listing
March 2015
37 Reads
4 Citations
3.404 Impact Factor

FLT3 expression and IL10 promoter polymorphism in acute myeloid leukemia with RUNX1-RUNX1T1.

Mol Biol Rep 2015 Feb 7;42(2):451-6. Epub 2014 Oct 7.

Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 137-701, Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs11033-014-37
Web Search
http://link.springer.com/10.1007/s11033-014-3786-1
Publisher Site
http://dx.doi.org/10.1007/s11033-014-3786-1DOI Listing
February 2015
38 Reads
1 Citation
2.024 Impact Factor

Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome.

Biol Blood Marrow Transplant 2015 Feb 20;21(2):342-9. Epub 2014 Nov 20.

Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.10.031DOI Listing
February 2015
44 Reads
4 Citations
3.404 Impact Factor

Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia.

Thromb Haemost 2015 Jan 23;113(1):201-8. Epub 2014 Oct 23.

Hee-Je, Kim, MD, PhD, Department of Hematology, Cancer Research Institute, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul 137-070, Korea, Tel.: +82 2 2258 6054; Fax: +82 2 599 3589, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH13-12-1020DOI Listing
January 2015
11 Reads
4.984 Impact Factor

A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.

Biol Blood Marrow Transplant 2015 Jan 6;21(1):119-29. Epub 2014 Oct 6.

Catholic Blood and Marrow Transplantation Center, Department of Hematology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Cancer Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.09.029DOI Listing
January 2015
68 Reads
6 Citations
3.404 Impact Factor

Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia

Thromb Haemost

Due to the high risk of thrombocytopenia and haemorrhage, thrombotic complications have received little attention in patients with acute myeloid leukemia (AML). Furthermore, the predictive role of cytogenetics on venous thromboembolism (VTE) has largely been ignored. This study aimed to evaluate the incidence, risk factors, and prognostic aspects of VTE in AML. A total of 811 consecutive patients with AML were enrolled and analysed retrospectively. Cox time-dependent covariate regression analysis was used to identify the significant predictors of VTE development. To minimise potential confounding factors, we used propensity-score matching to compare overall survival between patients with and without VTE. The six-month and one-year cumulative incidences of VTE were 3.1 % (95 % confidence interval [CI], 2.0-4.7) and 3.9 % (95 % CI, 2.6-5.7), respectively. Of the 26 cases of VTE, 22 (85 %) developed within 6 months of leukemia diagnosis and 13 (50 %) were catheter-related. In multivariate analysis, advanced age (≥ 65 years) (hazard ratio [HR], 2.70; p = 0.03) and increasing cytogenetic risk (common HR, 1.84; p = 0.05) were independent predictors of VTE. There was no significant association between VTE development and decreased survival (p = 0.32 for matched analysis). Advanced age and increasing cytogenetic risk, well-known predictors for clinical outcome in AML, were also independent risk factors of VTE development. Our results suggest that VTE does not hold prognostic implications for AML.

View Article
January 2015
13 Reads

ification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation

Marrow Transplant

Emerging molecular studies have identified a subgroup of patients with unfavorable core-binding factor-positive (CBF)-AML who should be treated by intensified post-remission treatments. We analyzed 264 adults with CBF-AML from 2002 to 2011, and focused on 206 patients who achieved CR after standard '3+7' induction chemotherapy. Patients who achieved CR with an available donor were treated with allogeneic hematopoietic SCT (allo-HSCT, n=115) and the rest were treated with autologous (auto) HSCT (n=72) or chemotherapy alone (n=19). OS was not significantly different between CBFβ/MYH11 (n=62) and RUNX1/RUNX1T1 (n=144), and auto-HSCT showed favorable OS compared with allo-HSCT or chemotherapy alone. Cytogenetic analysis identified that inv(16) without trisomy had a favorable OS and t(8;21) with additional chromosomes had an unfavorable OS, but multivariate analysis revealed those were NS. Patients with c-kit mutation showed inferior OS. For transplanted patients, residual post-transplant CBF-minimal residual disease quantitative PCR with higher WT1 expression at D+60 showed the worst OS with a higher incidence of relapse. Conclusively, we found that unfavorable CBF-AML can be defined with risk stratification using cytogenetic and molecular studies, and a careful risk-adapted treatment approach using frontline transplantation with novel therapies should be evaluated for this particular risk subgroup.

View Article
December 2014
9 Reads

Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL

Bone Marrow Transplant

We investigated the prognostic relevance of IKZF1 deletions in 118 adult Ph-positive ALL patients who had minimal residual disease (MRD) data under a uniform treatment of allo-SCT following first-line imatinib-based chemotherapy. IKZF1 deletions were identified in 93 patients (78.8%). IKZF1-deleted patients had a lower proportion of early-stable molecular responders compared with wild-type patients (28.0 vs 56.0%, P=0.028). After a median follow-up of 72 months, IKZF1-deleted patients had a trend for higher cumulative incidence of relapse (CIR) (38.0 vs 13.3%, P=0.052), particularly in a subgroup of early-stable molecular responders (n=40; 21.4 vs 0%, P=0.088), but comparable disease-free survival to wild-type patients. Patients with biallelic-null deletions showed higher CIR (74.6 vs 13.3%, P=0.003) and lower disease-free survival (20.0 vs 67.5%, P=0.022) than wild-type patients. In multivariate analysis, MRD kinetics were closely related to outcomes, while neither IKZF1 deletions nor their functional subtypes retained an independent statistical power. Within the limitation of sample size, however, considering both the negative impact of IKZF1 deletions on MRD kinetics and a trend for relationship between IKZF1 deletions and relapse in early-stable molecular responders, IKZF1 deletions may have a potentially additive effect on unfavorable prognosis in a specific MRD-based subgroup of adult Ph-positive ALL transplants.Bone Marrow Transplantation advance online publication, 15 December 2014; doi:10.1038/bmt.2014.281.

View Article
December 2014
7 Reads

(Lymph)angiogenic influences on hematopoietic cells in acute myeloid leukemia.

Exp Mol Med 2014 Nov 21;46:e122. Epub 2014 Nov 21.

Cancer Research Institute, Department of Hematology, Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/emm.2014.72DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262793PMC
November 2014
20 Reads
4 Citations
3.450 Impact Factor

Restoration of natural killer cell cytotoxicity by VEGFR-3 inhibition in myelogenous leukemia.

Cancer Lett 2014 Nov 23;354(2):281-9. Epub 2014 Aug 23.

Cancer Research Institute, Department of Hematology, Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2014.08.027DOI Listing
November 2014
3 Reads
4 Citations
5.621 Impact Factor

High ALDHdim-expressing CD34+CD38- cells in leukapheresed peripheral blood is a reliable guide for a successful leukemic xenograft model of acute myeloid leukemia.

Oncol Rep 2014 Oct 24;32(4):1638-46. Epub 2014 Jul 24.

Cancer Research Institute, Department of Hematology, Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2014.3359DOI Listing
October 2014
16 Reads
1 Citation
2.191 Impact Factor

Similar outcomes of peripheral blood stem cells vs. bone marrow for human leukocyte antigen-matched unrelated donor transplantation in adult patients with acute myeloid leukemia using risk-adapted graft-versus-host disease prophylaxis.

Eur J Haematol 2014 Jul 7;93(1):19-28. Epub 2014 Mar 7.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12287DOI Listing
July 2014
22 Reads
2.070 Impact Factor

Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation.

Transpl Int 2014 Jul 10;27(7):721-32. Epub 2014 May 10.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tri.12328DOI Listing
July 2014
26 Reads
1 Citation
2.600 Impact Factor

How old is old: the beginning of a new era for therapeutic challenges for elderly patients with AML.

Authors:
Hee-Je Kim

Blood Res 2014 Jun;49(2):75-6

Division of Hematology, Department of Internal Medicine, Cancer Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2014.49.2.75DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090338PMC
June 2014
7 Reads

PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL

Marrow Transplant

Few studies are available that compare PBSC and BM from unrelated donors, especially in adult high-risk ALL. To determine which graft source is superior in adult high-risk ALL, we analyzed the long-term outcomes of 106 consecutive transplants from 8/8-matched or 7/8-matched unrelated donors (38 PBSC vs 68 BM). All patients received a uniform strategy of pre-transplant therapy, myeloablative conditioning and GVHD prophylaxis. At 5 years, PBSC transplants showed higher incidence of chronic GVHD than did BM transplants (74.3% vs 46.7%, P=0.001). PBSC transplants showed outcomes comparable to those of BM transplants for relapse (23.7% vs 28.1%), non-relapse mortality (18.4% vs 25.0%), disease-free survival (57.9% vs 46.9%) and OS (57.9% vs 50.0%). In a separate comparison of outcomes between the two graft sources according to the presence of a Ph chromosome, no significant advantage of PBSC over BM was found in both subgroups of patients. Our data suggest that the outcomes of unrelated donor transplantation are similar between PBSC and BM in adult high-risk ALL. Whether PBSC should be the preferred graft source for a specific subgroup of adult ALL needs to be further investigated.

View Article
June 2014
13 Reads

Impact of failed response to novel agent induction in autologous stem cell transplantation for multiple myeloma.

Ann Hematol 2014 Apr 2;93(4):627-34. Epub 2013 Oct 2.

Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, #505, Banpo-dong, Seocho-gu, Seoul, 37-701, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-013-1911-1DOI Listing
April 2014
44 Reads
3 Citations
2.634 Impact Factor

Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities.

Blood Res 2014 Mar 24;49(1):22-8. Epub 2014 Mar 24.

Department of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2014.49.1.22DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974952PMC
March 2014
4 Reads
3 Citations

Influence of ex vivo purging with CliniMACS CD34(+) selection on outcome after autologous stem cell transplantation in non-Hodgkin lymphoma.

Br J Haematol 2014 Feb 25;164(4):555-64. Epub 2013 Nov 25.

Department of Haematology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12664DOI Listing
February 2014
5 Reads
1 Citation
4.711 Impact Factor

Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation?

Biol Blood Marrow Transplant 2014 Jan 20;20(1):80-8. Epub 2013 Oct 20.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.10.015DOI Listing
January 2014
18 Reads
1 Citation
3.404 Impact Factor

Implication of higher BAALC expression in combination with other gene mutations in adult cytogenetically normal acute myeloid leukemia.

Leuk Lymphoma 2014 Jan 12;55(1):110-20. Epub 2013 Jun 12.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, The Catholic University of Korea , Seoul , Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.800869DOI Listing
January 2014
11 Reads
2 Citations

Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status.

Am J Hematol 2013 Dec 12;88(12):1074-81. Epub 2013 Sep 12.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's hospital, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23576DOI Listing
December 2013
22 Reads
4 Citations
3.800 Impact Factor

Peripheral blood stem cell transplantation from human leukocyte antigen-matched sibling donors and unrelated donors in acute myeloid leukemia patients.

Acta Haematol 2013 26;130(3):206-16. Epub 2013 Jun 26.

Catholic Blood and Marrow Transplantation Center, The Catholic University of Korea, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000350481DOI Listing
December 2013
7 Reads
0.994 Impact Factor

Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia.

Eur J Haematol 2013 Nov 18;91(5):411-22. Epub 2013 Sep 18.

Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12167DOI Listing
November 2013
4 Reads
6 Citations
2.070 Impact Factor

Posaconazole treatment in Korea: single-center experience over 5 years.

Yonsei Med J 2013 Sep;54(5):1234-40

Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3349/ymj.2013.54.5.1234DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743190PMC
September 2013
24 Reads
1.263 Impact Factor

The impact of novel therapeutic agents before and after frontline autologous stem cell transplantation in patients with multiple myeloma.

Blood Res 2013 Sep 25;48(3):198-205. Epub 2013 Sep 25.

Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2013.48.3.198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786280PMC
September 2013
26 Reads

BAALC and WT1 expressions from diagnosis to hematopoietic stem cell transplantation: consecutive monitoring in adult patients with core-binding-factor-positive AML.

Eur J Haematol 2013 Aug 28;91(2):112-21. Epub 2013 Jun 28.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12142DOI Listing
August 2013
10 Reads
4 Citations
2.070 Impact Factor

Comparable long-term outcomes after reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high-risk acute lymphoblastic leukemia in complete remission.

Am J Hematol 2013 Aug 30;88(8):634-41. Epub 2013 May 30.

Department of Hematology, Catholic BMT Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea (South Korea).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23465DOI Listing
August 2013
133 Reads
4 Citations
3.800 Impact Factor

Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation.

Int J Hematol 2013 Jun 25;97(6):773-81. Epub 2013 Apr 25.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-013-1335-7DOI Listing
June 2013
20 Reads
1.680 Impact Factor

Serial measurement of WT1 expression and decrement ratio until hematopoietic cell transplantation as a marker of residual disease in patients with cytogenetically normal acute myelogenous leukemia.

Biol Blood Marrow Transplant 2013 Jun 27;19(6):958-66. Epub 2013 Mar 27.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.03.013DOI Listing
June 2013
21 Reads
3 Citations
3.404 Impact Factor

The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.

Ann Hematol 2013 Jun 15;92(6):817-24. Epub 2013 Jan 15.

Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 505 Banpo-Dong, Seocho-Gu, Seoul, 137-701, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-013-1674-8DOI Listing
June 2013
25 Reads
7 Citations
2.634 Impact Factor

Acute myeloid leukemia associated with FGFR1 abnormalities.

Int J Hematol 2013 Jun 23;97(6):808-12. Epub 2013 Apr 23.

Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s12185-013-1337
Web Search
http://link.springer.com/10.1007/s12185-013-1337-5
Publisher Site
http://dx.doi.org/10.1007/s12185-013-1337-5DOI Listing
June 2013
17 Reads
5 Citations
1.680 Impact Factor

Superior transplantation outcomes of 8/8-matched unrelated donors as well as matched siblings to autologous transplantation for acute myeloid leukemia with intermediate cytogenetics in first remission.

Eur J Haematol 2013 May 15;90(5):365-74. Epub 2013 Mar 15.

Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12089DOI Listing
May 2013
35 Reads
1 Citation
2.070 Impact Factor

Impact of pre-transplant marrow blasts on survival of allogeneic stem cell transplantation in adult acute myeloid leukemia.

Int J Hematol 2013 May 26;97(5):640-9. Epub 2013 Mar 26.

Department of Hematology, Catholic BMT Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, #505, Banpo-dong, Seocho-gu, Seoul 137-701, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-013-1312-1DOI Listing
May 2013
33 Reads
1.680 Impact Factor

A VEGFR-3 antagonist increases IFN-γ expression on low functioning NK cells in acute myeloid leukemia.

J Clin Immunol 2013 May 13;33(4):826-37. Epub 2013 Feb 13.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 505 Banpo 4-dong, Seocho-gu, Seoul, 137-701, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10875-013-9877-2DOI Listing
May 2013
11 Reads
5 Citations
3.184 Impact Factor

Improvement in hematopoiesis after iron chelation therapy with deferasirox in patients with aplastic anemia.

Acta Haematol 2013 15;129(2):72-7. Epub 2012 Nov 15.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000342772DOI Listing
April 2013
41 Reads
9 Citations
0.994 Impact Factor

Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy.

Ann Hematol 2013 Apr 20;92(4):497-504. Epub 2012 Nov 20.

Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-012-1632-xDOI Listing
April 2013
25 Reads
8 Citations
2.634 Impact Factor

Variant of ETV6/ABL1 gene is associated with leukemia phenotype.

Acta Haematol 2013 16;129(2):78-82. Epub 2012 Nov 16.

Department of Laboratory Medicine, Catholic Blood and Marrow Transplantation Center, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000342490DOI Listing
April 2013
15 Reads
6 Citations
0.994 Impact Factor

Clinical characteristics and the usefulness of the QuantiFERON-TB Gold In-Tube test in hematologic patients with hepatic or splenic lesions.

Korean J Intern Med 2013 Mar 27;28(2):187-96. Epub 2013 Feb 27.

Division of Infectious Diseases, Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital, Goyang, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2013.28.2.187DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604609PMC
March 2013
19 Reads
4 Citations

Expression of SOCS1 and SOCS3 genes in human graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Blood Res 2013 Mar 25;48(1):16-23. Epub 2013 Mar 25.

Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2013.48.1.16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625005PMC
March 2013
16 Reads
2 Citations

Response to pretransplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromes.

Eur J Haematol 2013 Feb 7;90(2):111-20. Epub 2013 Jan 7.

Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12038DOI Listing
February 2013
9 Reads
3 Citations
2.070 Impact Factor

KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.

Ann Hematol 2013 Jan 28;92(2):163-71. Epub 2012 Sep 28.

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-012-1580-5DOI Listing
January 2013
46 Reads
6 Citations
2.634 Impact Factor

Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category.

Genes Chromosomes Cancer 2013 Jan 28;52(1):44-55. Epub 2012 Sep 28.

Department of Laboratory Medicine, Ewha Womans University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22005DOI Listing
January 2013
8 Reads
5 Citations
4.041 Impact Factor

Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit.

J Crit Care 2012 Dec;27(6):739.e1-6

Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul 137-701, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcrc.2012.07.014DOI Listing
December 2012
14 Reads
10 Citations
2.191 Impact Factor

Comparison of allogeneic stem cell transplantation from familial-mismatched/haploidentical donors and from unrelated donors in adults with high-risk acute myelogenous leukemia.

Biol Blood Marrow Transplant 2012 Oct 16;18(10):1552-63. Epub 2012 Apr 16.

Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.04.008DOI Listing
October 2012
27 Reads
6 Citations
3.404 Impact Factor

Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes.

Biol Blood Marrow Transplant 2012 Jul 16;18(7):1136-43. Epub 2012 Jan 16.

Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, Seoul St Mary's Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.01.010DOI Listing
July 2012
28 Reads
5 Citations
3.400 Impact Factor

Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation.

Ann Hematol 2012 Mar 6;91(3):439-48. Epub 2011 Sep 6.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seocho-gu, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-011-1318-9DOI Listing
March 2012
4 Reads
2 Citations
2.630 Impact Factor

The premier statistical report of hematologic malignancies in Korea.

Authors:
Hee-Je Kim

Korean J Hematol 2012 Mar 28;47(1):1-2. Epub 2012 Mar 28.

Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/kjh.2012.47.1.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317465PMC
March 2012
5 Reads

Prognosis of invasive pulmonary aspergillosis in patients with hematologic diseases in Korea.

Tuberc Respir Dis (Seoul) 2012 Mar 31;72(3):284-92. Epub 2012 Mar 31.

Division of Infectious Diseases, Department of Internal Medicine, Ilsan Hospital, Goyang, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4046/trd.2012.72.3.284DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510278PMC
March 2012
13 Reads
3 Citations

FLANG salvage chemotherapy is an effective regimen that offers a safe bridge to transplantation for patients with relapsed or refractory acute myeloid leukemia.

Med Oncol 2011 Dec 17;28 Suppl 1:S462-70. Epub 2010 Aug 17.

Catholic Blood and Marrow Transplantation Center, The Catholic University of Korea College of Medicine, Seoul St Mary's Hospital, #505 Banpo-Dong, Seocho-Gu, Seoul 137-701, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-010-9653-6DOI Listing
December 2011
17 Reads
2 Citations
2.060 Impact Factor

Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia.

Leuk Lymphoma 2011 Dec 24;52(12):2321-8. Epub 2011 Oct 24.

Division of Hematology, Department of Internal Medicine, Yeouido St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.587562DOI Listing
December 2011
3 Reads
1 Citation

Survival benefits from reduced-intensity conditioning in allogeneic stem cell transplantation for young lower-risk MDS patients without significant comorbidities.

Eur J Haematol 2011 Dec 2;87(6):510-20. Epub 2011 Oct 2.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2011.01697.xDOI Listing
December 2011
6 Reads
2.070 Impact Factor

Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients.

Mycoses 2011 Nov 23;54(6):523-30. Epub 2011 May 23.

Division of Infectious Diseases, Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1439-0507.2010.02009.xDOI Listing
November 2011
6 Reads
6 Citations
1.800 Impact Factor

A case of pseudomembranous colitis after voriconazole therapy.

Yonsei Med J 2011 Sep;52(5):863-5

The Hematopoietic Stem Cell Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3349/ymj.2011.52.5.863DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159926PMC
September 2011
5 Reads
1.260 Impact Factor

Second primary glioblastoma multiforme following autologous hematopoietic stem cell transplantation in a patient with acute myelogenous leukemia.

Cancer Res Treat 2011 Sep 30;43(3):195-8. Epub 2011 Sep 30.

Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2011.43.3.195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192882PMC
September 2011
4 Reads
1 Citation
2.980 Impact Factor

Fortuitous detection of esophageal pneumatosis in a neutropenic patient.

Korean J Hematol 2011 Sep 30;46(3):151. Epub 2011 Sep 30.

Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/kjh.2011.46.3.151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208195PMC
September 2011
3 Reads
2 Citations

Vitamin B(12)-responsive pancytopenia mimicking myelodysplastic syndrome.

Acta Haematol 2011 20;125(4):198-201. Epub 2011 Jan 20.

Department of Laboratory Medicine, Catholic Blood and Marrow Transplantation Center, The Catholic University of Korea College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000322941DOI Listing
August 2011
18 Reads
3 Citations
0.990 Impact Factor

Reduced-intensity conditioning regimen combined with low-dose total body irradiation in the treatment of myelodysplastic syndrome.

Acta Haematol 2011 17;126(1):21-9. Epub 2011 Mar 17.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, The Catholic University of Korea, College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000323717DOI Listing
August 2011
12 Reads
0.990 Impact Factor

Bone scan images reveal increased osteoblastic function after bortezomib treatment in patients with multiple myeloma.

Eur J Haematol 2011 Jan 11;86(1):83-6. Epub 2010 Nov 11.

Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2010.01523.xDOI Listing
January 2011
15 Reads
4 Citations
2.070 Impact Factor

The Outcome of Unrelated Hematopoietic Stem Cell Transplants with Total Body Irradiation (800 cGy) and Cyclophosphamide (120 mg/kg) in Adult Patients with Acquired Severe Aplastic Anemia.

Biol Blood Marrow Transplant 2011 Jan 25;17(1):101-8. Epub 2010 Jun 25.

Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.06.014DOI Listing
January 2011
28 Reads
4 Citations
3.400 Impact Factor

Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.

Transplantation 2010 Oct;90(8):918-26

Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0b013e3181f24e8dDOI Listing
October 2010
6 Reads
17 Citations
3.830 Impact Factor

CD56 antigen expression and hemophagocytosis of leukemic cells in acute myeloid leukemia with t(16;21)(p11;q22).

Int J Hematol 2010 Sep 10;92(2):306-13. Epub 2010 Aug 10.

Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-010-0650-5DOI Listing
September 2010
15 Reads
4 Citations
1.680 Impact Factor

The characteristics and clinical outcome of adult patients with aplastic anemia and abnormal cytogenetics at diagnosis.

Genes Chromosomes Cancer 2010 Sep;49(9):844-50

Department of Hematology/Oncology, KonKuk University Hospital, KonKuk University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20793DOI Listing
September 2010
5 Reads
7 Citations
4.040 Impact Factor

Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and/or co-morbidities.

Int J Hematol 2010 Sep 10;92(2):342-50. Epub 2010 Aug 10.

Department of Hematology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-010-0649-yDOI Listing
September 2010
15 Reads
2 Citations
1.680 Impact Factor

A variant acute promyelocytic leukemia with t(11;17) (q23;q12); ZBTB16-RARA showing typical morphology of classical acute promyelocytic leukemia.

Korean J Hematol 2010 Jun 30;45(2):133-5. Epub 2010 Jun 30.

Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/kjh.2010.45.2.133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983015PMC
June 2010
13 Reads
2 Citations

Mutations in AML with a normal karyotype: NPM1 and FLT3-ITD, ready to use as a key prognosticator?

Authors:
Hee-Je Kim

Korean J Hematol 2010 Jun 30;45(2):79-80. Epub 2010 Jun 30.

Department of Internal Medicine, Division of Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/kjh.2010.45.2.79DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983019PMC
June 2010
3 Reads

High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantation.

Biol Blood Marrow Transplant 2010 May 4;16(5):629-38. Epub 2009 Dec 4.

Department of Hematology, Catholic Blood and Marrow Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.11.023DOI Listing
May 2010
28 Reads
6 Citations
3.400 Impact Factor

Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies.

Crit Care 2009 3;13(6):R173. Epub 2009 Nov 3.

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, College of Medicine, Catholic University of Korea, Seocho-Gu, Seoul 137-701, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/cc8149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811915PMC
April 2010
20 Reads
7 Citations

A case report of the second de novo acute myeloid leukemia (AML) following allogeneic stem cell transplantation in a patient with the first AML.

Korean J Intern Med 2010 Mar 26;25(1):110-3. Epub 2010 Feb 26.

Division of Hematology, Department of Internal Medicine, Catholic Blood and Marrow Transplantation Center, The Catholic University of Korea School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2010.25.1.110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829408PMC
March 2010
15 Reads
1 Citation

Bone marrow T cells are superior to splenic T cells to induce chimeric conversion after non-myeloablative bone marrow transplantation.

Korean J Intern Med 2009 Sep 26;24(3):252-62. Epub 2009 Aug 26.

Rheumatism Research Center, Catholic Research Institutes of Medical Science, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2009.24.3.252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732786PMC
September 2009
22 Reads
1 Citation

Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.

Biol Blood Marrow Transplant 2009 Jun 9;15(6):704-17. Epub 2009 Apr 9.

Division of Hematology, Department of Internal Medicine, Catholic Hemopoietic Stem Cell Transplantation Center, St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.02.010DOI Listing
June 2009
42 Reads
3 Citations
3.400 Impact Factor

Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells.

Int J Oncol 2009 Apr;34(4):1165-71

Division of Life Sciences, School of Life Sciences and Biotechnology, Korea University, Seoul 136-701, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo_00000245DOI Listing
April 2009
8 Reads
10 Citations
3.020 Impact Factor

The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease.

Am J Hematol 2008 Oct;83(10):784-8

Division of Hematology, Catholic Hematopoietic Stem Cell Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21227DOI Listing
October 2008
4 Reads
4 Citations
3.800 Impact Factor

The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.

Transplantation 2007 Nov;84(9):1082-91

Catholic Hemopoietic Stem Cell Transplantation Center, Catholic University of Korea College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.tp.0000285918.72930.35DOI Listing
November 2007
2 Reads
6 Citations
3.830 Impact Factor

Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.

Biol Blood Marrow Transplant 2007 Sep 20;13(9):1083-94. Epub 2007 Jul 20.

Catholic Hematopoietic Stem Cell Transplantation Center, College of Medicine, The Catholic University of Korea, St. Mary's Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2007.06.001DOI Listing
September 2007
6 Reads
14 Citations
3.400 Impact Factor

Successful interim therapy with imatinib prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute myeloid leukemia.

Eur J Haematol 2007 Aug 28;79(2):170-3. Epub 2007 Jun 28.

Division of Hematology, Department of Internal Medicine, Catholic Hemopoietic Stem Cell Transplantation Center, Catholic University of Korea College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2007.00890.xDOI Listing
August 2007
16 Reads
1 Citation
2.070 Impact Factor

Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide.

Biol Blood Marrow Transplant 2007 Jul 24;13(7):863-70. Epub 2007 May 24.

Division of Hematology, Catholic Hematopoietic Stem Cell Transplantation Center, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2007.03.013DOI Listing
July 2007
4 Reads
4 Citations
3.400 Impact Factor

Interpretation of interleukin-2 receptor alpha positive cells during induction chemotherapy for adult acute myelogenous leukaemia patients.

Hematol Oncol 2007 Jun;25(2):76-83

Division of Hematology, Department of Internal Medicine, Catholic Hemopoietic Stem Cell Transplantation Center, Catholic University of Korea College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.807DOI Listing
June 2007
5 Reads
3.080 Impact Factor

[A case of therapy-related acute myeloid leukemia associated with inv(16)].

Korean J Lab Med 2007 Feb;27(1):19-21

Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
February 2007
6 Reads
1 Citation
1.310 Impact Factor

[A Case of Acute Myeloid Leukemia with Masked t(8;21).].

Korean J Lab Med 2006 Oct;26(5):338-42

Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
October 2006
4 Reads
1.310 Impact Factor

Efficacy of up-front treatment with a double stem cell transplantation in multiple myeloma.

Jpn J Clin Oncol 2006 Jul 16;36(7):432-8. Epub 2006 Jun 16.

Catholic Hematopoietic Stem Cell Transplantation Center, St Mary's Hospital, Catholic University of Korea, Youngdungpo-Gu, Seoul 150-713, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyl041DOI Listing
July 2006
10 Reads
1 Citation
1.750 Impact Factor

The significance of minimal residual disease kinetics in adults with newly diagnosed PML-RARalpha-positive acute promyelocytic leukemia: results of a prospective trial.

Haematologica 2006 May 19;91(5):671-4. Epub 2006 Apr 19.

Catholic Hematopoietic Stem Cell Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
May 2006
10 Reads
3 Citations
5.870 Impact Factor

Clinical characteristics and outcomes of posttransplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation in Korea.

J Korean Med Sci 2006 Apr;21(2):259-64

Department of Internal Medicine, The Catholic Hematopoietic Stem Cell Transplantation Center, The Catholic University of Korea, College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734001PMC
http://dx.doi.org/10.3346/jkms.2006.21.2.259DOI Listing
April 2006
6 Reads
1 Citation
1.250 Impact Factor

Fas, Fas-associated death domain-like interleukin 1beta-converting enzyme-like inhibitory protein, and apoptotic features of elderly acute myeloid leukemia based on response to induction chemotherapy.

Int J Hematol 2005 Nov;82(4):327-32

Division of Hematology, Department of Internal Medicine, Catholic Hemopoietic Stem Cell Transplantation Center, Catholic University of Korea College of Medicine, Seoul.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1532/IJH97.A30503DOI Listing
November 2005
8 Reads
1.680 Impact Factor

Comparison of 2 preparative regimens for stem cell transplantation from HLA-matched sibling donors in patients with advanced myelodysplastic syndrome.

Int J Hematol 2005 Jul;82(1):66-71

Catholic Hematopoietic Stem Cell Transplantation Center, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1532/IJH97.A30501DOI Listing
July 2005
12 Reads
1.680 Impact Factor

The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

Blood 2005 May 18;105(9):3449-57. Epub 2005 Jan 18.

Department of Hematology, St Mary's Hospital, The Catholic University of Korea, 62 Youido-Dong, Youngdeungpo-Ku, Seoul 150-713, Korea (South).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-09-3785DOI Listing
May 2005
67 Reads
27 Citations
10.450 Impact Factor

Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea.

Int J Hematol 2005 Jan;81(1):69-74

The Catholic Hematopoietic Stem Cell Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.

View Article

Download full-text PDF

Source
January 2005
5 Reads
7 Citations
1.680 Impact Factor

Megadose CD34+ hemopoietic stem cell transplantation for patients with high risk acute myeloid leukemia who have no HLA matched donor--a pilot study of a full haplotype mismatch transplantation.

Korean J Intern Med 2004 Dec;19(4):243-9

Division of Hematology, Department of Internal Medicine, Catholic Hemopoietic Stem Cell Transplantation Center, The Catholic University of Korea College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531581PMC
http://dx.doi.org/10.3904/kjim.2004.19.4.243DOI Listing
December 2004
9 Reads

Top co-authors

Seok Lee
Seok Lee

College of Medicine

61
Woo-Sung Min
Woo-Sung Min

The Catholic University of Korea

55
Sung-Eun Lee
Sung-Eun Lee

The Catholic University of Korea

55
Jae-Ho Yoon
Jae-Ho Yoon

The Catholic University of Korea

54
Ki-Seong Eom
Ki-Seong Eom

The Catholic University of Korea

49
Seok-Goo Cho
Seok-Goo Cho

The Catholic University of Korea

49
Byung-Sik Cho
Byung-Sik Cho

The Catholic University of Korea

48
Jong-Wook Lee
Jong-Wook Lee

The Catholic University of Korea

31